Both PDE inhibition and GUCY2C activation effectively upregulate Ser40 phosphorylation, thereby boosting dopamine production, and are able to improve motor deficits in the 6-OHDA Parkinson's disease model. Here, ALDH7A1 is linked to Parkinson disease.